Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis
Xin Yin, Xu Teng, Tianyu Ma, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 11, pp. 2203-2217
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 99
Histone deacetylase complexes: Structure, regulation and function
Moges Dessale Asmamaw, 阿形 清和, Lirong Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189150-189150
Closed Access | Times Cited: 13
Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics
Zhixing Zhong, Junchen Hou, Zhixian Yao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner
Yuanbo Hu, Chenbin Chen, Kezhi Lin, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access | Times Cited: 1
The Role of PPARs in Breast Cancer
Binggong Zhao, Zhiqiang Xin, Ping Ren, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 35
RUNX2 and Cancer
Tsung‐Chieh Lin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7001-7001
Open Access | Times Cited: 16
Cell-cycle dependent nuclear gene delivery enhances the effects of E-cadherin against tumor invasion and metastasis
Liting Xie, Jieqiong Wang, L. M. Song, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response
Richard S. Lee, Kirti Sad, Dorelle V. Fawwal, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 4005-4005
Open Access | Times Cited: 14
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells
Fengxu Lv, Wentao Si, Xiaodan Xu, et al.
Neoplasia (2024) Vol. 48, pp. 100967-100967
Open Access | Times Cited: 5
RUNX transcription factors: biological functions and implications in cancer
Xinyi Chen, Lu Wang, Mu Yang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy
Fahad Alsaikhan
Environmental Research (2023) Vol. 237, pp. 116951-116951
Closed Access | Times Cited: 12
Exosomes from LSD1 knockdown breast cancer cells activate osteoclastogenesis and inhibit osteoblastogenesis
Ziyu Liu, Nan Zhang, Benkai Xin, et al.
International Journal of Biological Macromolecules (2023) Vol. 235, pp. 123792-123792
Closed Access | Times Cited: 11
Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma
Jiazhou Ye, Yan Lin, Zhiling Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma
Baozhen Wang, Yichen Yin, Anqi Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Super-enhancer-hijacking RBBP7 potentiates metastasis and stemness of breast cancer via recruiting NuRD complex subunit LSD1
Yuanyin Xi, Ruoding Wang, Man Qu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
From Molecular Mechanisms to Therapeutic Targets: Research Progress of RUNX2 in Cancer
韫 熊
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1572-1579
Closed Access
USF1-activated hsa_circ_0076691 induces oxaliplatin resistance via facilitating FGF9 expression in miR-589-3p-dependent manners
Lingyu Tang, Xuan Deng, Ming Guan, et al.
Non-coding RNA Research (2025)
Open Access
CUL4B regulates thyroid cancer differentiation and treatment sensitivity by ubiquitinating ARID1A
Haiyan Gu, Bo Han, Jing Hu, et al.
Translational Oncology (2025) Vol. 56, pp. 102389-102389
Closed Access
HBV activates hepatic stellate cells through RUNX2/ITGBL1 axis
Fengchun Shi, Wei Tan, Wei Huang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
GSK3 acts as a switch for transcriptional programs in a model of low-grade gliomagenesis
Marilin Koch, Minh Deo, Laurent Schmitt, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination
Binggong Zhao, Wei Huo, Xiaomin Yu, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 717-733
Open Access | Times Cited: 10
Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks
Sepideh Mirzaei, Bijan Ranjbar, Saeed Hesami Tackallou, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154676-154676
Closed Access | Times Cited: 10
A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency
Xue Yang, Artem Smirnov, Oreste Claudio Buonomo, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis
Selvaraj Vimalraj, Saravanan Sekaran
Cancers (2023) Vol. 15, Iss. 12, pp. 3247-3247
Open Access | Times Cited: 7
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Yuyi Han, Valentina Rovella, Artem Smirnov, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top